ID: ALA2372410

Max Phase: Preclinical

Molecular Formula: C31H43N5O7S2

Molecular Weight: 661.85

Molecule Type: Small molecule

Associated Items:

Representations

Canonical SMILES:  C[C@@H]1NC(=O)[C@@H](NC(=O)[C@@H](N)Cc2ccc(O)cc2)C(C)(C)SSC(C)(C)[C@@H](C(O)O)NC(=O)[C@H](Cc2ccccc2)NC1=O

Standard InChI:  InChI=1S/C31H43N5O7S2/c1-17-25(38)34-22(16-18-9-7-6-8-10-18)27(40)36-24(29(42)43)31(4,5)45-44-30(2,3)23(28(41)33-17)35-26(39)21(32)15-19-11-13-20(37)14-12-19/h6-14,17,21-24,29,37,42-43H,15-16,32H2,1-5H3,(H,33,41)(H,34,38)(H,35,39)(H,36,40)/t17-,21-,22-,23+,24+/m0/s1

Standard InChI Key:  RUNRDTYBZFTQFP-QCIOSCQESA-N

Associated Targets(Human)

Monoamine oxidase A 11911 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Associated Targets(non-human)

Monoamine oxidase 439 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Monoamine oxidase B 894 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Mu opioid receptor 3620 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Delta opioid receptor 3127 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Mu opioid receptor 6060 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Delta opioid receptor 3911 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Properties

Molecular Weight: 661.85Molecular Weight (Monoisotopic): 661.2604AlogP: 0.73#Rotatable Bonds: 7
Polar Surface Area: 203.11Molecular Species: NEUTRALHBA: 10HBD: 8
#RO5 Violations: 2HBA (Lipinski): 12HBD (Lipinski): 9#RO5 Violations (Lipinski): 3
CX Acidic pKa: 9.48CX Basic pKa: 7.73CX LogP: 0.99CX LogD: 0.63
Aromatic Rings: 2Heavy Atoms: 45QED Weighted: 0.15Np Likeness Score: 1.04

References

1. Sablin SO, Krueger MJ, Singer TP, Bachurin SO, Khare AB, Efange SM, Tkachenko SE..  (1994)  Interaction of tetrahydrostilbazoles with monoamine oxidase A and B.,  37  (1): [PMID:8289189] [10.1021/jm00027a019]
2. Haaseth RC, Horan PJ, Bilsky EJ, Davis P, Zalewska T, Slaninova J, Yamamura HI, Weber SJ, Davis TP, Porreca F..  (1994)  [L-Ala3]DPDPE: a new enkephalin analog with a unique opioid receptor activity profile. Further evidence of delta-opioid receptor multiplicity.,  37  (11): [PMID:8201592] [10.1021/jm00037a007]
3. Efange SM, Michelson RH, Remmel RP, Boudreau RJ, Dutta AK, Freshler A..  (1990)  Flexible N-methyl-4-phenyl-1,2,3,6-tetrahydropyridine analogues: synthesis and monoamine oxidase catalyzed bioactivation.,  33  (12): [PMID:2258899] [10.1021/jm00174a007]
4. Mabic S, Castagnoli N..  (1996)  Assessment of structural requirements for the monoamine oxidase-B-catalyzed oxidation of 1,4-disubstituted-1,2,3,6-tetrahydropyridine derivatives related to the neurotoxin 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine.,  39  (19): [PMID:8809158] [10.1021/jm9603882]
5. Kalgutkar AS, Castagnoli N..  (1992)  Synthesis of novel MPTP analogs as potential monoamine oxidase B (MAO-B) inhibitors.,  35  (22): [PMID:1433219] [10.1021/jm00100a023]

Source